Filing Details

Accession Number:
0001562180-23-007189
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2023-10-03 19:32:22
Reporting Period:
2022-02-03
Accepted Time:
2023-10-03 19:32:22
Original Submission Date:
2022-02-03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1603756 Axonics Inc. AXNX Surgical & Medical Instruments & Apparatus (3841) 454744083
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1756438 L. Danny Dearen 26 Technology Drive
Irvine CA 92618
President & Cfo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-03 36,919 $0.00 57,919 No 4 M Direct
Common Stock Disposition 2022-02-03 17,737 $48.21 40,182 No 4 S Direct
Common Stock Disposition 2022-02-03 947 $49.03 39,235 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. This amendment is being filed to address an error in reporting the amount of securities beneficially owned following reported transactions on February 3, 2022. Accordingly, this amendment is being filed to amend and restate this line from the Original Form 4 in its entirety. This Form 4 acts as an amendment for all subsequently filed Form 4s.
  2. Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein.
  3. This transaction was executed in multiple trades at prices ranging from $47.76 to $48.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $48.78 to $49.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.